Anna Army

Manager, Portfolio Comms at @IpsenUS | Public Relations @NewhouseSU '20 | previously: @LaVoieGroup @SUPRSSA @HillCommPR

[Anna Army @AnnaArmy_SYR]

https://t.co/NM4Jn2c6z1

[Anna Army @AnnaArmy_SYR]

https://t.co/fdX4geuuEQ

[Anna Army @AnnaArmy_SYR]

https://t.co/zaSsHuk8L3

[Anna Army @AnnaArmy_SYR]

https://t.co/YDB2CaDTvT

[Boston Health Care for the Homeless Program @BHCHP]

Join us at Ipsen's first Invitational Golf Tournament on Aug 28! Held at TPC Norton, all proceeds raised from the event will directly benefit BHCHP. Thank you @IpsenUS and see you on the greens soon! https://t.co/4N3yi7zaeB

[Taylor Swift @taylorswift13]

Last night we all danced together in the rain for THE ENTIRE 3.5 HOUR SHOW in foxy Foxborough MA!! We’ve had rain shows at Gillette Stadium before but this was a full on deluge that never let up, I just want to thank that iconic crowd!! Love you so much you have no idea 💕🥰🥲

[Gillette Stadium @GilletteStadium]

Tonight we got to dance in the pouring rain with Taylor Swift (again).

We will NEVER forget it.

🥹🫶

[The Mighty @TheMightySite]

#RareDisease patients share their advice for navigating relationships and finding community.

#Sponsored by @IpsenUS https://t.co/i9ubraK5Bb

[Life Science Cares @LS_Cares]

@IpsenUS continues its top-to-bottom support for Life Science Cares with the addition of Stewart Campbell to our Board of Advisors. We are thrilled to harness Stewart’s commitment to giving back toward our mission to disrupt the cycle of poverty & inequality in our community!

[American Liver Foundation National @liverUSA]

Join us in thanking our Autoimmune Liver Disease Forum lead sponsor, @IpsenUS! We are so appreciative of their continued commitment to the American Liver Foundation’s mission and support of our successful forum.

[Anna Army @AnnaArmy_SYR]

We’re live kicking things off at the Simmons Leadership Conference ! Excited to be here. 🌟 #SLCBoston #RenewalandInnovation @IpsenUS

[Anna Army @AnnaArmy_SYR]

Join us today in honor of #RareDiseaseDay in partnership with @TheMightySite for an exciting event about the social impact of living with a rare disease: https://t.co/575PTXdmY5

[TG Therapeutics @TGTherapeutics]

#Breaking: @US_FDA has approved our new therapy for relapsing forms of multiple sclerosis! We want to thank the patients & families, clinical trial staff, investigators & the TG team for making this approval possible! PR: https://t.co/ooQwG6E1Qz #RMS #MS #FearlessforScience $TGTX

[Latest News from Business Wire @NewsFromBW]

Novadip Biosciences SA Appoints Judy Ashworth, MD, as Chief Medical Officer https://t.co/KToiwSxUi9

[Outlook Therapeutics @OutlookTx]

The EMA has validated Outlook Therapeutics' MAA for ONS-5010, an investigational ophthalmic formulation of bevacizumab, for the treatment of #wetAMD. Decision for potential approval is expected from European Commission in early 2024. Read more: https://t.co/WTTqV6NWsO $OTLK

[Brent Warner 🇺🇸🇮🇹 @iambrentwarner]

An interesting look at the preclinical data we shared at #ASH22 on our P-FVIII-101 in vivo gene therapy program in Hemophilia A, which we are developing in partnership with @TakedaPharma.

Read the full article from @FierceBiotech here: https://t.co/EmQoj1f7Ba

#genetherapy

[FierceBiotech @FierceBiotech]

Takeda's $3.6 billion deal with Poseida Therapeutics is paying off with promising preclinical data on the companies’ hemophilia A therapy P-FVIII-101.
https://t.co/jlGpplbG7L

[Anna Army @AnnaArmy_SYR]

Incredible journalism - please read this. Kudos to @NicholasFlorko and @statnews.

[Nicholas Florko @NicholasFlorko]

STAT just published an eight part series I’ve worked on for the last two years. I’ll have more to say in the AM. But for now, ill just say please read it, and that I’m so thankful to the folks who shared their stories, and all my great colleagues here. https://t.co/jqk7yy4Iib

[Anna Army @AnnaArmy_SYR]

https://t.co/VSWi2ydKVe